Cart

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

The aim of this study was to evaluate the effects of chronic treatment with CBD (10 mg/kg, i.p.) on PD‐associated neurodegenerative and neuro-inflammatory processes, and motor deficits in the 6‐hydroxydopamine model. Moreover, the article investigated the potential mechanisms by which CBD exerted its effects in this model. CBD‐treated animals showed a reduction of nigrostriatal degeneration accompanied by a damping of the neuro-inflammatory response and an improvement of motor performance.

 

Click below for the full research article;

Parkinson

 

Goodbody has no- association with the organisation that conducted this research and is not in a position to validate the research methods, results or conclusions of the published article. It is provided for awareness of research available that may be of interest only. Any reader should read a range of articles and research to have a balanced and informed view.



Goodbody is a trading name of Goodbody Botanicals Ltd a member of the Sativa Wellness Group Inc.

Goodbody products are not intended to treat, diagnose, cure or prevent any disease. The information and products presented on this site are not intended for medical use nor do they make any medical claims. Always seek the advice of your physician or another qualified healthcare provider for any questions you have regarding a medical condition, and before undertaking any diet, exercise or other health related program.

Copyright © 2021 Goodbody Botanicals Ltd

Company

Goodbody Botanicals Ltd
The Blue Building
Stubbs Lane
Beckington
BA11 6TE


* For further details about the Sativa Wellness Group please click here